S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
CVE:BCT

BriaCell Therapeutics Corp. (BCT.V) Stock Forecast, Price & News

C$4.72
-0.23 (-4.65 %)
(As of 12/4/2020 03:58 PM ET)
Add
Compare
Today's Range
C$4.71
Now: C$4.72
C$5.11
50-Day Range
C$4.75
MA: C$5.24
C$5.52
52-Week Range
C$4.61
Now: C$4.72
C$27.00
Volume1,107 shs
Average Volume1,027 shs
Market CapitalizationC$3.64 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-9211810
Employees5

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.09 per share
Book ValueC($4.95) per share

Profitability

Miscellaneous

Market CapC$3.64 million
Next Earnings Date3/1/2021 (Estimated)
OptionableNot Optionable
C$4.72
-0.23 (-4.65 %)
(As of 12/4/2020 03:58 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BCT News and Ratings via Email

Sign-up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











BriaCell Therapeutics Corp. (BCT.V) (CVE:BCT) Frequently Asked Questions

How has BriaCell Therapeutics Corp. (BCT.V)'s stock been impacted by Coronavirus (COVID-19)?

BriaCell Therapeutics Corp. (BCT.V)'s stock was trading at C$17.80 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BCT stock has decreased by 73.5% and is now trading at C$4.72.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than BriaCell Therapeutics Corp. (BCT.V)?

Wall Street analysts have given BriaCell Therapeutics Corp. (BCT.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BriaCell Therapeutics Corp. (BCT.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is BriaCell Therapeutics Corp. (BCT.V)'s next earnings date?

BriaCell Therapeutics Corp. (BCT.V) is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for BriaCell Therapeutics Corp. (BCT.V)
.

Who are some of BriaCell Therapeutics Corp. (BCT.V)'s key competitors?

What other stocks do shareholders of BriaCell Therapeutics Corp. (BCT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BriaCell Therapeutics Corp. (BCT.V) investors own include Brainstorm Cell Therapeutics (BCLI), Gene Biotherapeutics (CRXM), Organovo (ONVO), Anavex Life Sciences (AVXL), Actinium Pharmaceuticals (ATNM), Cytokinetics (CYTK), Genmab A/S (GNMSF), Inovio Pharmaceuticals (INO), Isoray (ISR) and Medidata Solutions (MDSO).

Who are BriaCell Therapeutics Corp. (BCT.V)'s key executives?

BriaCell Therapeutics Corp. (BCT.V)'s management team includes the following people:
  • Dr. William V. Williams M.D., CEO, Pres & Director
  • Dr. Charles Louis Wiseman M.D., FACP, Founder & Director
  • Mr. Gadi Levin B.Com., C.A., M.B.A., CPA, MBA, CFO & Corp. Sec. (Age 47, Pay $56.07k)
  • Ms. Farrah Dean, Mang. of Corp. Devel.

What is BriaCell Therapeutics Corp. (BCT.V)'s stock symbol?

BriaCell Therapeutics Corp. (BCT.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BCT."

How do I buy shares of BriaCell Therapeutics Corp. (BCT.V)?

Shares of BCT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is BriaCell Therapeutics Corp. (BCT.V)'s stock price today?

One share of BCT stock can currently be purchased for approximately C$4.72.

How big of a company is BriaCell Therapeutics Corp. (BCT.V)?

BriaCell Therapeutics Corp. (BCT.V) has a market capitalization of C$3.64 million. BriaCell Therapeutics Corp. (BCT.V) employs 5 workers across the globe.

What is BriaCell Therapeutics Corp. (BCT.V)'s official website?

The official website for BriaCell Therapeutics Corp. (BCT.V) is www.briacell.com.

How can I contact BriaCell Therapeutics Corp. (BCT.V)?

BriaCell Therapeutics Corp. (BCT.V)'s mailing address is Bellevue Centre, 235 15th St 3rd Floor, WEST VANCOUVER, BC V7T 2X1, Canada. The company can be reached via phone at +1-604-9211810.

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.